Some studies have indicated that L-carnitine has a beneficial effect on enhancing physical performance
[23] In the diseased brain, GLP-1 receptor agonist treatment is associated with protection against a range of experimental disease models such as Parkinson's disease, [24] [18] Alzheimer's disease, [25] [26] stroke, [24] traumatic brain injury, [14] [19] and multiple sclerosis
The scientific interest in this combination stems from the possibility of observing, in controlled experimental models, complementary biological pathways involved in cellular migration, stress response, actin dynamics, and structural repair processes
In simplest terms, obesity first means we treat obesity as a priority when confronting these obesity-associated disorders
Neuropharmacology 25 , 125131 (1986)
This underscores the importance of a carefully managed discontinuation plan, which is yet to be standardized in clinical guidelines